PRECIPIO, INC. Revenue from Contract with Customer, Excluding Assessed Tax
PRECIPIO, INC. (PRPO) reported Revenue from Contract with Customer, Excluding Assessed Tax of $7.02 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-14
- PRECIPIO, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $7.02M, a 24.73% increase year-over-year.
- PRECIPIO, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $6.96M, a 41.74% increase year-over-year.
- PRECIPIO, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $6.82M, a 28.43% increase year-over-year.
- PRECIPIO, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $6.88M, a 30.40% increase year-over-year.
- PRECIPIO, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $24.25M, a 30.52% increase from fiscal 2024.
- PRECIPIO, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $18.58M, a 20.51% increase from fiscal 2023.
- PRECIPIO, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $15.41M, a 56.98% increase from fiscal 2022.
- PRECIPIO, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $9.82M, a 12.91% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.02M 10-Q · filed 2026-08-14 | $13.98M 10-Q · filed 2026-08-14 | $20.80M derived: sum of 3 quarters · filed 2026-08-14 | $27.69M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $6.96M 10-Q · filed 2026-05-14 | $13.78M derived: sum of 2 quarters · filed 2026-05-14 | $20.67M derived: sum of 3 quarters · filed 2026-05-14 | $26.30M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $6.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $13.71M derived: sum of 2 quarters · filed 2026-03-30 | $19.34M derived: sum of 3 quarters · filed 2026-08-14 | $24.25M 10-K · filed 2026-03-30 |
| 2025-09-30 | $6.88M 10-Q · filed 2025-11-14 | $12.51M derived: sum of 2 quarters · filed 2026-08-14 | $17.43M 10-Q · filed 2025-11-14 | $22.74M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $5.63M 10-Q · filed 2026-08-14 | $10.54M 10-Q · filed 2026-08-14 | $15.85M derived: sum of 3 quarters · filed 2026-08-14 | $21.13M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $4.91M 10-Q · filed 2026-05-14 | $10.22M derived: sum of 2 quarters · filed 2026-05-14 | $15.50M derived: sum of 3 quarters · filed 2026-05-14 | $20.01M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $5.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $10.59M derived: sum of 2 quarters · filed 2026-03-30 | $15.10M derived: sum of 3 quarters · filed 2026-03-30 | $18.58M 10-K · filed 2026-03-30 |
| 2024-09-30 | $5.28M 10-Q · filed 2025-11-14 | $9.79M derived: sum of 2 quarters · filed 2025-11-14 | $13.27M 10-Q · filed 2025-11-14 | $17.64M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $4.51M 10-Q · filed 2025-08-13 | $7.99M 10-Q · filed 2025-08-13 | $12.36M derived: sum of 3 quarters · filed 2025-08-13 | $16.93M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $3.48M 10-Q · filed 2025-05-14 | $7.85M derived: sum of 2 quarters · filed 2025-05-14 | $12.42M derived: sum of 3 quarters · filed 2025-05-14 | $16.06M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $4.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $8.94M derived: sum of 2 quarters · filed 2025-03-27 | $12.59M derived: sum of 3 quarters · filed 2025-03-27 | $15.41M 10-K · filed 2025-03-27 |
| 2023-09-30 | $4.57M 10-Q · filed 2024-11-06 | $8.21M derived: sum of 2 quarters · filed 2024-11-06 | $11.04M 10-Q · filed 2024-11-06 | $13.60M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $3.65M 10-Q · filed 2024-08-13 | $6.47M 10-Q · filed 2024-08-13 | $9.03M derived: sum of 3 quarters · filed 2024-08-13 | $11.32M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $2.83M 10-Q · filed 2024-05-14 | $5.38M derived: sum of 2 quarters · filed 2024-05-14 | $7.68M derived: sum of 3 quarters · filed 2024-05-14 | $10.12M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $4.85M derived: sum of 2 quarters · filed 2024-03-29 | $7.29M derived: sum of 3 quarters · filed 2024-03-29 | $9.82M 10-K · filed 2024-03-29 |
| 2022-09-30 | $2.29M 10-Q · filed 2023-11-13 | $4.74M derived: sum of 2 quarters · filed 2023-11-13 | $7.27M 10-Q · filed 2023-11-13 | $9.47M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $2.45M 10-Q · filed 2023-08-11 | $4.97M 10-Q · filed 2023-08-11 | $7.18M derived: sum of 3 quarters · filed 2023-08-11 | $9.31M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $2.53M 10-Q · filed 2023-05-12 | $4.73M derived: sum of 2 quarters · filed 2023-05-12 | $6.87M derived: sum of 3 quarters · filed 2023-05-12 | $9.11M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $4.34M derived: sum of 2 quarters · filed 2023-03-30 | $6.59M derived: sum of 3 quarters · filed 2023-03-30 | $8.70M 10-K · filed 2023-03-30 |
| 2021-09-30 | $2.14M 10-Q · filed 2022-11-10 | $4.38M derived: sum of 2 quarters · filed 2022-11-10 | $6.49M 10-Q · filed 2022-11-10 | $8.75M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $2.24M 10-Q · filed 2022-08-11 | $4.36M 10-Q · filed 2022-08-11 | $6.61M derived: sum of 3 quarters · filed 2022-08-11 | $8.66M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $2.11M 10-Q · filed 2022-05-11 | $4.37M derived: sum of 2 quarters · filed 2022-05-11 | $6.42M derived: sum of 3 quarters · filed 2022-05-11 | $8.06M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $4.30M derived: sum of 2 quarters · filed 2022-03-30 | $5.95M derived: sum of 3 quarters · filed 2022-03-30 | $7.43M 10-K · filed 2022-03-30 |
| 2020-09-30 | $2.05M 10-Q · filed 2021-11-12 | $3.69M derived: sum of 2 quarters · filed 2021-11-12 | $5.18M 10-Q · filed 2021-11-12 | $6.11M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $1.65M 10-Q · filed 2021-08-12 | $3.13M 10-Q · filed 2021-08-12 | $4.06M derived: sum of 3 quarters · filed 2021-08-12 | $5.11M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $1.48M 10-Q · filed 2021-05-14 | $2.42M derived: sum of 2 quarters · filed 2021-05-14 | $3.46M derived: sum of 3 quarters · filed 2021-05-14 | $4.66M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $933.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $1.98M derived: sum of 2 quarters · filed 2021-03-29 | $3.18M derived: sum of 3 quarters · filed 2021-03-29 | $4.09M 10-K · filed 2021-03-29 |
| 2019-09-30 | $1.05M 10-Q · filed 2020-11-13 | $2.25M derived: sum of 2 quarters · filed 2020-11-13 | $3.16M 10-Q · filed 2020-11-13 | $4.03M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $1.20M 10-Q · filed 2020-08-13 | $2.12M 10-Q · filed 2020-08-13 | $2.99M derived: sum of 3 quarters · filed 2020-08-13 | $3.81M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $917.00K 10-Q · filed 2020-05-14 | $1.79M derived: sum of 2 quarters · filed 2020-05-14 | $2.61M derived: sum of 3 quarters · filed 2020-05-14 | $3.57M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $870.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $1.69M derived: sum of 2 quarters · filed 2020-03-27 | $2.65M derived: sum of 3 quarters · filed 2020-03-27 | $3.45M 10-K · filed 2020-03-27 |
| 2018-09-30 | $823.00K 10-Q · filed 2019-11-13 | $1.78M derived: sum of 2 quarters · filed 2019-11-13 | $2.58M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $959.00K 10-Q · filed 2019-08-09 | $1.75M 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $796.00K 10-Q · filed 2019-05-16 | |||
| 2017-12-31 | $2.03M 10-K · filed 2019-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |